1593. Recurrence of Clostridium difficile Infection in Multiple Myeloma Patients Receiving Prophylactic Oral Vancomycin or Oral Metronidazole vs. No Prophylaxis

BACKGROUND: Multiple myeloma (MM) patients are at increased risk of Clostridium difficile infection (CDI) compared with the general population. In prior studies, 12–14% were diagnosed with CDI, and ~16% had recurrent CDI during subsequent treatments. Recent studies have shown that oral vancomycin is...

Descripción completa

Detalles Bibliográficos
Autores principales: Moran, Gisele, Yarlagadda, Naveen, Susanibar, Sandra, Kothari, Atul, Rico, Juan Carlos, Burgess, Mary J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253229/
http://dx.doi.org/10.1093/ofid/ofy210.1421

Ejemplares similares

Ejemplares similares